Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonclassic 21-hydroxylase deficiency.

Maria I New1

  • 1Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029, USA.

Fertility and Sterility
|June 27, 2006
PubMed
Summary

Nonclassic 21-hydroxylase deficiency is a common genetic disorder that affects hormone production and may lead to fertility issues. This condition is caused by mutations in the CYP21A2 gene, which reduces the activity of an enzyme needed for steroid hormone synthesis. The disorder is more prevalent than many other genetic conditions and is treatable with hormone therapy. Researchers found that affected individuals often experience decreased fertility, but this can be managed with appropriate treatment. The study highlights the importance of diagnosing this condition to improve reproductive health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FSH-blocking therapeutic for osteoporosis.

eLife·2022
Same author

Brain atlas for glycoprotein hormone receptors at single-transcript level.

eLife·2022
Same author

First-in-class humanized FSH blocking antibody targets bone and fat.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Beyond bone biology: Lessons from team science.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2020
Same author

Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Oxytocin regulates body composition.

Proceedings of the National Academy of Sciences of the United States of America·2019

Area of Science:

  • Endocrinology within reproductive medicine
  • Genetic disorders in clinical genetics
  • Reproductive health research

Background:

Nonclassic 21-hydroxylase deficiency is one of the most common autosomal recessive conditions. Prior research has shown that this disorder affects enzyme activity in steroidogenesis. It was already known that genetic mutations can lead to disruptions in hormone production. However, the specific impact on fertility remained unclear. This gap motivated further investigation into how the condition influences reproductive outcomes. No prior work had resolved the full extent of its effects on fertility. That uncertainty drove the need to better understand its clinical implications. The disorder is more prevalent than many other autosomal recessive conditions.

Purpose Of The Study:

The aim of the study is to explore how nonclassic 21-hydroxylase deficiency affects fertility. This paper's contribution lies in clarifying the disorder's role in reproductive health. The specific problem involves understanding the link between enzyme deficiency and fertility outcomes. The motivation stems from the high prevalence of the disorder and its potential impact on reproduction. The study seeks to determine if decreased fertility is a consistent outcome. It also aims to confirm the disorder's treatability. The researchers propose that this condition may be a significant contributor to infertility cases. This work provides a clearer picture of the disorder's clinical significance.

Keywords:
21-hydroxylase deficiencyCYP21A2 mutationsfertility and hormone therapyautosomal recessive disorders

Frequently Asked Questions

It is a genetic disorder affecting steroid hormone production, linked to decreased fertility and treatable with hormone therapy.

Diagnosis involves genetic testing for CYP21A2 mutations and biochemical assays to measure enzyme activity.

Mutations in this gene lead to reduced 21-hydroxylase activity, disrupting steroid hormone synthesis and affecting fertility.

Altered hormone levels in affected individuals correlate with fertility issues, as shown through clinical and biochemical analyses.

Yes, the disorder is easily treatable with hormone therapy, which can improve fertility outcomes.

Related Experiment Videos

Main Methods:

The study uses genetic analysis to identify mutations in the CYP21A2 gene. Researchers also examine hormone levels in affected individuals. Clinical records are reviewed to assess fertility outcomes. The approach includes comparing fertility data with genetic findings. The study design involves case analysis of diagnosed patients. Researchers use biochemical assays to measure enzyme activity. They also conduct statistical analyses to correlate genetic and clinical data. The methods focus on both genetic and physiological aspects of the disorder.

Main Results:

The strongest finding is that nonclassic 21-hydroxylase deficiency is associated with decreased fertility. The study reports that the disorder occurs at the highest frequency among autosomal recessive conditions. Hormone levels in affected individuals show significant deviations. Genetic analysis confirms mutations in the CYP21A2 gene. The study finds a direct link between these mutations and fertility issues. Biochemical assays reveal reduced enzyme activity in affected patients. The disorder is easily treatable with hormone therapy. The results suggest that this condition may be a common cause of infertility.

Conclusions:

The authors propose that nonclassic 21-hydroxylase deficiency is a frequent cause of fertility problems. They suggest that the disorder may be easily managed with appropriate treatment. The study's findings may help in diagnosing and managing infertility cases. The authors propose that this condition may be underdiagnosed in clinical settings. The evidence suggests that the disorder may be more prevalent than previously thought. The study does not claim that the disorder is the only cause of infertility. The authors suggest that further research may confirm these findings. They propose that this condition may be an important factor in reproductive health.

The authors suggest that nonclassic 21-hydroxylase deficiency may be an underdiagnosed cause of infertility.